On the one hand, we overexpressed SRM in PGC1α-expressing cells to counteract the reduced expression and secretion of this enzyme elicited by the coactivator in PC3 prostate cancer cells (Fig. 4B and Supplementary Fig. 4B). Here, PPARGC1A is linked to prostate carcinoma.